Volume 30, Supplement - Infectious Diseases and Carceral Health
SUPPLEMENT ISSUE
Outbreaks and Investigations
Candida auris in US Correctional Facilities
Ian Hennessee
, Kaitlin Forsberg, Jalysa Erskine, Argentina Charles, Barbara Russell, Juliana Reyes, Chantel Emery, Nickolas Valencia, Adrienne Sherman, Jason Mehr, Hannah Gallion, Brandon Halleck, Caleb Cox, Marcie Bryant, Deborah Nichols, Magdalena Medrzycki, D. Cal Ham, Liesl M. Hagan, and Meghan Lyman
, Kaitlin Forsberg, Jalysa Erskine, Argentina Charles, Barbara Russell, Juliana Reyes, Chantel Emery, Nickolas Valencia, Adrienne Sherman, Jason Mehr, Hannah Gallion, Brandon Halleck, Caleb Cox, Marcie Bryant, Deborah Nichols, Magdalena Medrzycki, D. Cal Ham, Liesl M. Hagan, and Meghan Lyman
Table
Characteristics of 13 patients who were discharged to correctional facilities after having a positive Candida auris specimen, January 2020–December 2022*
| Characteristic | Value |
|---|---|
| Case information | |
| C. auris case type | |
| Screening | 11 (85) |
| Clinical | 2 (15) |
| Healthcare facility type where positive specimens were collected | |
| Acute care hospital | 10 (77) |
| Long-term acute care hospital |
3 (23) |
| Demographic information, medical devices, and underlying conditions at the time of transfer | |
| Age, y, median (range) | 55 (26–66) |
| Sex | |
| M | 12 (92) |
| F | 1 (8) |
| Mechanical ventilation | 3 (23) |
| Indwelling medical devices | 5 (38) |
| Central venous catheter | 2 (15) |
| Urinary catheter | 2 (15) |
| Tracheostomy | 2 (15) |
| Feeding tube | 2 (15) |
| Underlying chronic conditions | 12 (92) |
| Chronic kidney disease† | 8 (62) |
| Type 2 diabetes | 7 (54) |
| Cardiovascular disease | 5 (38) |
| Chronic wounds |
2 (15) |
| Correctional facility where patient was transferred | |
| State prison | 12 (92) |
| Federal prison |
1 (8) |
| Transfer location within correctional facility | |
| Onsite medical unit | 9 (69) |
| Onsite medical unit, then to general population unit | 1 (8) |
| General population unit | 1 (8) |
| Unknown | 2 (15) |
*Values are no. (%) except as indicated. †Including end-stage renal disease (n = 4).
Page created: August 31, 2023
Page updated: March 31, 2024
Page reviewed: March 31, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.